Corbus Pharmaceuticals Holdings, Inc. Accumulated Other Comprehensive Income
Corbus Pharmaceuticals Holdings, Inc. (CRBP) had Accumulated Other Comprehensive Income of -$107.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-06
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$107.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$161.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$53.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$3.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2026-06-30 | -$107.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | -$161.00K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | -$53.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | -$3.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | -$39.00K 10-Q · filed 2025-08-05 | |
| 2025-03-31 | -$23.00K 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $35.00K 10-K · filed 2026-03-09 | |
| 2024-09-30 | $207.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | -$388.00K 10-Q · filed 2024-08-06 | |
| 2024-03-31 | -$328.50K 10-Q · filed 2024-05-07 | |
| 2023-12-31 | -$1.00K 10-K · filed 2025-03-11 | -$1.56K 10-K · filed 2024-03-12 |
| 2023-09-30 | -$8.04K 10-Q · filed 2023-11-07 | |
| 2023-06-30 | -$23.79K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | -$68.47K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | -$126.09K 10-K · filed 2024-03-12 | |
| 2022-09-30 | -$206.87K 10-Q · filed 2022-11-08 | |
| 2022-06-30 | -$119.32K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | -$169.69K 10-Q · filed 2022-05-10 | |
| 2021-12-31 | -$62.45K 10-K · filed 2023-03-07 | |
| 2021-09-30 | -$8.97K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | -$5.45K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | -$28.77K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |